New Key Statistics Module, Z-Score and F-Score
OTCPK:ONPPF Key Ratios
| Market Cap $ M | 30.01 |
| Enterprise Value $ M | 18.02 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.35 |
| Price/Sales | 8.58 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2.00 |
| EPS (TTM) $ | -0.19 |
| Beneish M-Score | -3.56 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 26.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.69 |
| EV-to-EBITDA | -0.69 |
| PEG | -- |
| Shares Outstanding M | 211.26 |
| Net Margin (%) | -1,043.15 |
| Operating Margin % | -1,042.60 |
| Pre-tax Margin (%) | -1,036.91 |
| Quick Ratio | 6.16 |
| Current Ratio | 6.25 |
| ROA % (ttm) | -93.81 |
| ROE % (ttm) | -276.66 |
| ROIC % (ttm) | -346.86 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.84 |
ONPPF Number of Guru Trades
ONPPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:ONPPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ONPPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Oncopeptides AB Insider Transactions
No Available Data
News about OTCPK:ONPPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers